Francisca Rojo-Cortés

Francisca Rojo-Cortés

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZRZohra Rahmani
Zohra Rahmani
Satya SurbhiSatya Surbhi
Satya Surbhi
FRFrancisca Rojo-Cortés
Francisca Rojo-Cortés
DDDulac Dulac
Dulac Dulac
AJAndreas Jenny
Andreas Jenny
Serge BirmanSerge Birman
Serge Birman
Parkinson disease (PD) is a common neurodegenerative condition affecting people predominantly at old age that is characterized by a progressive loss of midbrain dopaminergic neurons and by the accumulation of α-synuclein-containing intraneuronal inclusions known as Lewy bodies. Defects in cellular degradation processes such as the autophagy-lysosomal pathway are suspected to be involved in PD progression. The mammalian Lysosomal-associated membrane proteins LAMP1 and LAMP2 are transmembrane glycoproteins localized in lysosomes and late endosomes that are involved in autophagosome/lysosome maturation and function. Here, we show that the lack of Drosophila Lamp1, the homolog of LAMP1 and LAMP2, severely increased fly susceptibility to paraquat, a pro-oxidant compound known as a potential PD inducer in humans. Moreover, the loss of Lamp1 also exacerbated the progressive locomotor defects induced by the expression of PD-associated mutant α-synuclein A30P (α-synA30P) in dopaminergic neurons. Remarkably, the ubiquitous re-expression of Lamp1 in a mutant context fully suppressed all these defects and conferred significant resistance towards both PD factors above that of wild-type flies. Immunostaining analysis showed that the brain levels of α-synA30P were unexpectedly decreased in young adult Lamp1-deficient flies expressing this protein in comparison to non-mutant controls. This suggests that Lamp1 could neutralize α-synuclein toxicity by promoting the formation of non-pathogenic aggregates in neurons. Overall, our findings reveal a novel role for Drosophila Lamp1 in protecting against oxidative stress and α-synuclein neurotoxicity in PD models, thus furthering our understanding of the function of its mammalian homologs.

5 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
RZRafaella V. Zárate
Rafaella V. Zárate
SHSergio Hidalgo
Sergio Hidalgo
NNNicole Navarro
Nicole Navarro
DMDaniela Molina-Mateo
Daniela Molina-Mateo
DRDuxan Andres Arancibia Radich
Duxan Andres Arancibia Radich
JCJorge M Campusano
Jorge M Campusano
Parkinson’s disease (PD) is a neurodegenerative disease characterized by motor symptoms and dopaminergic cell loss. A pre-symptomatic phase characterized by non-motor symptoms precedes the onset of motor alterations. Two recent PET studies in human carriers of mutations associated with familial PD demonstrate an early serotonergic commitment—alteration in SERT binding—before any dopaminergic or motor dysfunction, that is, at putative PD pre-symptomatic stages. These findings support the hypothesis that early alterations in the serotonergic system could contribute to the progression of PD, an idea difficult to be tested in humans. Here, we study some components of the serotonergic system during the pre-symptomatic phase in a well-characterized Drosophila PD model, Pink1B9 mutant flies. We detected lower brain serotonin content in Pink1B9 flies, accompanied by reduced activity of SERT before the onset of motor dysfunctions. We also explored the consequences of a brief early manipulation of the serotonergic system in the development of motor symptoms later in aged animals. Feeding young Pink1B9 flies with fluoxetine, a SERT blocker, prevents the loss of dopaminergic neurons and ameliorates motor impairment observed in aged mutant flies. Surprisingly, the same pharmacological manipulation in young control flies results in aged animals exhibiting a PD-like phenotype. Our findings support that an early dysfunction in the serotonergic system precedes and contributes to the onset of the Parkinsonian phenotype in Drosophila.

20 December 2024 in eLife
Verified
Journal Article
Open access
JSJun Sun
Jun Sun
FRFrancisca Rojo-Cortés
Francisca Rojo-Cortés
SUSuzana Ulian-Benitez
Suzana Ulian-Benitez
Manuel Guillermo ForeroManuel Guillermo Forero
Manuel Guillermo Forero
GLGuiyi Li
Guiyi Li
Alicia HidalgoAlicia Hidalgo
Alicia Hidalgo
Experience shapes the brain as neural circuits can be modified by neural stimulation or the lack of it. The molecular mechanisms underlying structural circuit plasticity and how plasticity modifies behaviour are poorly understood. Subjective experience requires dopamine, a neuromodulator that assigns a value to stimuli, and it also controls behaviour, including locomotion, learning, and memory. In Drosophila, Toll receptors are ideally placed to translate experience into structural brain change. Toll-6 is expressed in dopaminergic neurons (DANs), raising the intriguing possibility that Toll-6 could regulate structural plasticity in dopaminergic circuits. Drosophila neurotrophin-2 (DNT-2) is the ligand for Toll-6 and Kek-6, but whether it is required for circuit structural plasticity was unknown. Here, we show that DNT-2-expressing neurons connect with DANs, and they modulate each other. Loss of function for DNT-2 or its receptors Toll-6 and kinase-less Trk-like kek-6 caused DAN and synapse loss, impaired dendrite growth and connectivity, decreased synaptic sites, and caused locomotion deficits. In contrast, over-expressed DNT-2 increased DAN cell number, dendrite complexity, and promoted synaptogenesis. Neuronal activity modified DNT-2, increased synaptogenesis in DNT-2-positive neurons and DANs, and over-expression of DNT-2 did too. Altering the levels of DNT-2 or Toll-6 also modified dopamine-dependent behaviours, including locomotion and long-term memory. To conclude, a feedback loop involving dopamine and DNT-2 highlighted the circuits engaged, and DNT-2 with Toll-6 and Kek-6 induced structural plasticity in this circuit modifying brain function and behaviour.

5 August 2026 in Biology Open
Verified
Journal Article
Open access
NANaser Alshamsi
Naser Alshamsi
FRFrancisca Rojo-Cortés
Francisca Rojo-Cortés
JFJervis Fernandes
Jervis Fernandes
CPCallum Perrett
Callum Perrett
BZBangfu Zhu
Bangfu Zhu
Alicia HidalgoAlicia Hidalgo
Alicia Hidalgo
During vertebrate nervous system development, neurons are produced in excess and those receiving neurotrophin ligands are maintained, enabling neural circuit establishment. An apoptotic wave sweeps across the Drosophila pupal visual system, but whether neurotrophins participate in forming adult visual circuits remained unknown. Here, we show that Drosophila Neurotrophin-3 (spz-3) and DNT-2 (spz-5) are expressed in retinal cells and medulla neurons, and Toll receptors across the visual system. Using loss and gain of function conditions for DNT-3 (spz-3) and DNT-2 (spz-5) we show that they both can, and are required to, promote cell survival. Importantly, genetic interaction data show that DNT-2 can function together with Toll-2. DNT-2 neurons were identified as medulla Mi1 neurons that connect to lamina L1 neurons expressing Toll-2. Loss of function for DNT-2 or Toll-2 induced apoptosis, and Toll-2 knock-down prevented the pro-survival function of DNT-2. DNT-2 over-expression resulted in excess Toll-2 neurons, whereas most Toll-2 neurons were lost in DNT-2 mutants. Furthermore, DNT-2 and Toll-2 were required for appropriate L1 axonal columnar organisation and dendritic morphology. Altogether, evolutionarily conserved neurotrophin family ligands control neuronal number through Toll receptors during visual circuit development in Drosophila.

28 January 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
FRFrancisca Rojo-Cortés
Francisca Rojo-Cortés
CRCandy Roa-Siegfried
Candy Roa-Siegfried
PAPaula Amado-Hinojosa
Paula Amado-Hinojosa
NFNicolás Fuenzalida-Uribe
Nicolás Fuenzalida-Uribe
MGMaría-Constanza González-Ramírez
María-Constanza González-Ramírez
JCJorge M Campusano
Jorge M Campusano
Reelin is a secreted glycoprotein with roles in the development of the mammalian neocortex, hippocampus, and cerebellum. This vertebrate signaling molecule also contributes to adult brain function. Mammalian Reelin increases the complexity of Drosophila Mushroom Body (MB) neurites, an effect mediated by LpR1 and LpR2, the orthologs of mammalian Reelin receptors. Paradoxically, to date, no Reelin ortholog has been described in Drosophila . Here, we report that the protein product of the uncharacterized Drosophila CG17739 gene, which we named Drospondin, shares sequence homology with vertebrate F-spondin and Reelin. We show that Drospondin is expressed in glial cells and is crucial for MB development. Our results also show that Drospondin genetically interacts with LpRs and that human Reelin rescues neuronal and brain structural defects in Drospondin-deficient flies. Furthermore, Drospondin-deficient flies exhibit altered sleep, locomotion, and social behaviors. Our results reveal that Drospondin is a Drosophila protein with similar functions to mammalian Reelin/F-spondin, that has an essential role in brain development and function, the impairment of which has profound functional consequences for the animal.

11 December 2024 in eLife preprints
Verified
Preprint
Open access
JSJun Sun
Jun Sun
FRFrancisca Rojo-Cortés
Francisca Rojo-Cortés
SUSuzana Ulian-Benitez
Suzana Ulian-Benitez
Manuel Guillermo ForeroManuel Guillermo Forero
Manuel Guillermo Forero
GLGuiyi Li
Guiyi Li
Alicia HidalgoAlicia Hidalgo
Alicia Hidalgo
Experience shapes the brain, as neural circuits can be modified by neural stimulation or the lack of it. The molecular mechanisms underlying structural circuit plasticity and how plasticity modifies behaviour, are poorly understood. Subjective experience requires dopamine, a neuromodulator that assigns a value to stimuli, and it also controls behaviour, including locomotion, learning and memory. In Drosophila, Toll receptors are ideally placed to translate experience into structural brain change. Toll-6 is expressed in dopaminergic neurons (DANs), raising the intriguing possibility that Toll-6 could regulate structural plasticity in dopaminergic circuits. Drosophila neurotrophin-2 (DNT-2) is the ligand for Toll-6 and Kek-6, but whether it is required for circuit structural plasticity was unknown. Here, we show that DNT-2 expressing neurons connect with DANs, and they modulate each other. Loss of function for DNT-2 or its receptors Toll-6 and kinase-less Trk-like kek-6 caused DAN and synapse loss, impaired dendrite growth and connectivity, decreased synaptic sites and caused locomotion deficits. By contrast, over-expressed DNT-2 increased DAN cell number, dendrite complexity and promoted synaptogenesis. Neuronal activity modified DNT-2, it increased synaptogenesis in DNT-2-positive neurons and DANs, and over-expression of DNT-2 did too. Altering the levels of DNT-2 or Toll-6 also modified dopamine-dependent behaviours, including locomotion and long-term memory. To conclude, a feedback loop involving dopamine and DNT-2 sculpted the circuits engaged, and DNT-2 with Toll-6 and Kek-6 induced structural plasticity in this circuit modifying brain function and behaviour.